Gluten exposure increases intestinal permeability and systemic inflammatory signaling in genetically susceptible people.

An extensive body of scientific research supports the link between gluten exposure, increased intestinal permeability, and systemic inflammatory signaling in genetically susceptible individuals.

Mechanisms of Barrier Disruption and Translocation

• Zonulin-Mediated Tight Junction Disassembly: Ingested gluten contains immunogenic gliadin peptides that bind to CXCR3 chemokine receptors on intestinal epithelial cells. This interaction triggers a MyD88-dependent release of zonulin, a physiological modulator of intercellular tight junctions.
• Increased Intestinal Permeability: Excess extracellular zonulin initiates a signaling cascade that disassembles the tight junction protein complexes (such as occludin and zonula occludens-1), leading to increased paracellular permeability (often referred to as a "leaky gut").
• Endotoxin Translocation: The compromised epithelial barrier allows gut-derived luminal antigens and microbial products—specifically Gram-negative bacterial lipopolysaccharide (LPS)—to translocate out of the intestinal lumen and enter the lamina propria and systemic circulation.

Systemic Inflammatory Signaling

• Innate Immune Activation: Once in the bloodstream, circulating LPS binds to LPS-binding protein (LBP) and activates Toll-like Receptor 4 (TLR4) on systemic immune cells (monocytes and macrophages).
• Cytokine Cascade: Activation of TLR4 drives the transcription and systemic secretion of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1-beta (IL-1β), promoting extra-intestinal inflammatory signaling.

Role of Genetic Susceptibility

• HLA-DQ2/DQ8 Influence: The pathological impact of gluten is highly modulated by genetic predisposition, specifically the expression of human leukocyte antigen (HLA) class II molecules HLA-DQ2 or HLA-DQ8.
• Permeability Differences: Clinical trials in irritable bowel syndrome (IBS-D) demonstrate that dietary gluten increases small-bowel permeability (measured by urinary lactulose-to-mannitol ratios), and this barrier-disrupting effect is significantly more pronounced in HLA-DQ2/8-positive individuals compared to HLA-negative patients. In HLA-DQ2/8-positive hosts, deamidated gliadin peptides are presented efficiently to T-cells, triggering a robust adaptive immune response alongside the innate inflammatory cascade.

Bottom line

In genetically susceptible individuals (HLA-DQ2/8 positive), gluten exposure triggers a pathological zonulin-mediated increase in intestinal permeability. This allows bacterial LPS to translocate into the bloodstream, where it stimulates TLR4 receptors to drive systemic, extra-intestinal inflammatory cytokine signaling.